| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.23e-05 | 188 | 82 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 9.94e-05 | 4 | 82 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | structural molecule activity | DLGAP1 ABI3BP MAP4 MUC17 COL27A1 DAG1 LMNB2 DMBT1 MUC2 MUC3A AGRN MRPL35 | 2.70e-04 | 891 | 82 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | laminin binding | 3.64e-04 | 34 | 82 | 3 | GO:0043236 | |
| GeneOntologyBiologicalProcess | dendrite development | NEDD4L ABI3BP HECW2 ZNF212 ULK4 AFDN RTN4IP1 NLGN1 RERE NCK2 | 8.48e-07 | 335 | 82 | 10 | GO:0016358 |
| GeneOntologyBiologicalProcess | neuron projection development | EVL NEDD4L NRXN1 ABI3BP TRIO MAP4 MYO7A HECW2 ZNF212 DAG1 ULK4 AFDN RTN4IP1 NLGN1 RERE AGRN NCK2 | 9.82e-06 | 1285 | 82 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of presynaptic active zone assembly | 1.56e-05 | 2 | 82 | 2 | GO:1905518 | |
| GeneOntologyBiologicalProcess | positive regulation of presynaptic active zone assembly | 1.56e-05 | 2 | 82 | 2 | GO:1905520 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion involved in synapse maturation | 1.56e-05 | 2 | 82 | 2 | GO:0090125 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transmembrane transporter activity | 3.27e-05 | 16 | 82 | 3 | GO:2000650 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EVL NEDD4L NRXN1 ABI3BP TRIO MYO7A HECW2 DAG1 AFDN NLGN1 RERE AGRN | 3.82e-05 | 748 | 82 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transmembrane transport | 3.96e-05 | 17 | 82 | 3 | GO:1902306 | |
| GeneOntologyBiologicalProcess | regulation of neuromuscular synaptic transmission | 4.67e-05 | 3 | 82 | 2 | GO:1900073 | |
| GeneOntologyBiologicalProcess | positive regulation of neuromuscular synaptic transmission | 4.67e-05 | 3 | 82 | 2 | GO:1900075 | |
| GeneOntologyBiologicalProcess | regulation of NMDA receptor activity | 4.73e-05 | 18 | 82 | 3 | GO:2000310 | |
| GeneOntologyBiologicalProcess | neuron development | EVL NEDD4L NRXN1 ABI3BP TRIO MAP4 MYO7A HECW2 ZNF212 DAG1 ULK4 AFDN RTN4IP1 NLGN1 RERE AGRN NCK2 | 5.18e-05 | 1463 | 82 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EVL DLC1 NEDD4L NRXN1 ABI3BP TRIO MYO7A HECW2 COL27A1 DAG1 AFDN NLGN1 RERE MUC3A AGRN | 6.44e-05 | 1194 | 82 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 7.28e-05 | 56 | 82 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 7.65e-05 | 21 | 82 | 3 | GO:0099151 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transport | 8.83e-05 | 22 | 82 | 3 | GO:0010766 | |
| GeneOntologyBiologicalProcess | positive regulation of presynapse assembly | 9.32e-05 | 4 | 82 | 2 | GO:1905608 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EVL NEDD4L NRXN1 ABI3BP TRIO HECW2 DAG1 AFDN NLGN1 RERE MUC3A AGRN | 9.89e-05 | 826 | 82 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.39e-04 | 198 | 82 | 6 | GO:0048813 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic specialization assembly | 1.47e-04 | 26 | 82 | 3 | GO:0099150 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 1.47e-04 | 26 | 82 | 3 | GO:1904889 | |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling by trans-synaptic protein complex | 1.55e-04 | 5 | 82 | 2 | GO:0098942 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 1.55e-04 | 5 | 82 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 1.65e-04 | 27 | 82 | 3 | GO:1905874 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 2.30e-04 | 309 | 82 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | NMDA glutamate receptor clustering | 2.32e-04 | 6 | 82 | 2 | GO:0097114 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 2.49e-04 | 141 | 82 | 5 | GO:0060996 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.93e-04 | 663 | 82 | 10 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.96e-04 | 664 | 82 | 10 | GO:0099177 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 3.11e-04 | 148 | 82 | 5 | GO:1902414 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EVL NEDD4L NRXN1 ABI3BP TRIO HECW2 DAG1 AFDN NLGN1 RERE AGRN | 3.24e-04 | 802 | 82 | 11 | GO:0048812 |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 3.32e-04 | 34 | 82 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EVL NEDD4L NRXN1 ABI3BP TRIO HECW2 DAG1 AFDN NLGN1 RERE AGRN | 3.87e-04 | 819 | 82 | 11 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuronal signal transduction | 4.30e-04 | 8 | 82 | 2 | GO:0023041 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EVL NEDD4L NRXN1 ABI3BP MAP4 HECW2 ULK4 AFDN RTN4IP1 NLGN1 AGRN | 5.08e-04 | 846 | 82 | 11 | GO:0120035 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 5.18e-04 | 93 | 82 | 4 | GO:0099068 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 5.49e-04 | 256 | 82 | 6 | GO:0032412 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EVL NEDD4L NRXN1 ABI3BP MAP4 HECW2 ULK4 AFDN RTN4IP1 NLGN1 AGRN | 5.99e-04 | 863 | 82 | 11 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 6.66e-04 | 43 | 82 | 3 | GO:2000463 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 6.69e-04 | 175 | 82 | 5 | GO:0031644 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 6.71e-04 | 266 | 82 | 6 | GO:0022898 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 6.88e-04 | 10 | 82 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 6.88e-04 | 10 | 82 | 2 | GO:1990709 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 7.13e-04 | 44 | 82 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 7.17e-04 | 612 | 82 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | negative regulation of plasma membrane bounded cell projection assembly | 7.62e-04 | 45 | 82 | 3 | GO:0120033 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | EVL TREX1 EXOSC10 DLC1 NRXN1 ABI3BP MAP4 HECW2 DLGAP5 CEP295 NLGN1 SPECC1L AGRN NCK2 | 7.73e-04 | 1342 | 82 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | EVL DLC1 NEDD4L NRXN1 ABI3BP MAP4 DAG1 ULK4 AFDN CEP295 NLGN1 AGRN NCK2 | 7.91e-04 | 1189 | 82 | 13 | GO:0044087 |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 8.13e-04 | 46 | 82 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 8.39e-04 | 11 | 82 | 2 | GO:0097119 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 8.39e-04 | 11 | 82 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by trans-synaptic complex | 8.39e-04 | 11 | 82 | 2 | GO:0099545 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 8.59e-04 | 185 | 82 | 5 | GO:0099175 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 8.81e-04 | 387 | 82 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 9.92e-04 | 395 | 82 | 7 | GO:0050803 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 1.15e-03 | 115 | 82 | 4 | GO:0035418 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.18e-03 | 13 | 82 | 2 | GO:0097090 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 1.23e-03 | 299 | 82 | 6 | GO:0032409 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.27e-03 | 202 | 82 | 5 | GO:0051963 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 1.44e-03 | 56 | 82 | 3 | GO:0001941 | |
| GeneOntologyCellularComponent | Golgi lumen | MUC3B RHBDF2 MUC17 DAG1 MUC16 MUC5B MUC12 MUC2 MUC3A AGRN MUC20 | 6.25e-13 | 109 | 84 | 11 | GO:0005796 |
| GeneOntologyCellularComponent | external encapsulating structure | SSC5D FREM2 ABI3BP MUC17 COL27A1 DAG1 MUC5B DMBT1 MUC2 PKHD1L1 AGRN | 6.38e-05 | 658 | 84 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | protein complex involved in cell-cell adhesion | 2.37e-04 | 6 | 84 | 2 | GO:0098635 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.75e-04 | 530 | 84 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.95e-04 | 656 | 84 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.83e-04 | 85 | 84 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | actin-based cell projection | 8.95e-04 | 278 | 84 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.20e-03 | 523 | 84 | 8 | GO:0098984 | |
| HumanPheno | Abnormal external nose morphology | FREM2 TREX1 NEDD4L TRIO HECW2 COL27A1 KMT2A CEP295 SPECC1L RERE SRCAP RFX7 NEK9 LUZP1 | 3.78e-05 | 916 | 26 | 14 | HP:0010938 |
| HumanPheno | Clinodactyly | NEDD4L TRIO COL27A1 KMT2A CEP295 LMNB2 SPECC1L RERE SRCAP RFX7 LUZP1 | 5.34e-05 | 574 | 26 | 11 | HP:0030084 |
| HumanPheno | Disordered formal thought process | 7.34e-05 | 386 | 26 | 9 | HP:0025769 | |
| HumanPheno | Abnormal stomach morphology | TREX1 DLC1 NEDD4L RHBDF2 NRXN1 KMT2A MUC5B RERE SRCAP AGRN NEK9 LUZP1 | 1.13e-04 | 742 | 26 | 12 | HP:0002577 |
| HumanPheno | Syndactyly | 1.34e-04 | 417 | 26 | 9 | HP:0001159 | |
| HumanPheno | Clinodactyly of the 5th finger | 1.42e-04 | 420 | 26 | 9 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 1.44e-04 | 421 | 26 | 9 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 1.44e-04 | 421 | 26 | 9 | HP:0009179 | |
| HumanPheno | Long philtrum | 1.67e-04 | 429 | 26 | 9 | HP:0000343 | |
| HumanPheno | Deviation of finger | NEDD4L TRIO COL27A1 KMT2A LMNB2 SPECC1L RERE SRCAP NEK9 LUZP1 | 1.73e-04 | 537 | 26 | 10 | HP:0004097 |
| HumanPheno | Radial deviation of finger | 2.33e-04 | 448 | 26 | 9 | HP:0009466 | |
| HumanPheno | Finger clinodactyly | 2.49e-04 | 452 | 26 | 9 | HP:0040019 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | NEDD4L TRIO COL27A1 KMT2A LMNB2 SPECC1L RERE SRCAP NEK9 LUZP1 | 2.61e-04 | 564 | 26 | 10 | HP:0009484 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 2.67e-04 | 456 | 26 | 9 | HP:0009485 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 3.38e-04 | 368 | 26 | 8 | HP:0031432 | |
| HumanPheno | Perseverative thought | 3.98e-04 | 377 | 26 | 8 | HP:0030223 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 4.37e-04 | 30 | 26 | 3 | HP:0005743 | |
| HumanPheno | Female pseudohermaphroditism | 5.18e-04 | 7 | 26 | 2 | HP:0010458 | |
| HumanPheno | Generalized hypertrichosis | 5.18e-04 | 7 | 26 | 2 | HP:0004554 | |
| HumanPheno | Self-injurious behavior | 5.26e-04 | 210 | 26 | 6 | HP:0100716 | |
| HumanPheno | Diagnostic behavioral phenotype | TRIO MYO7A HECW2 KMT2A NLGN1 SPECC1L RERE SRCAP RFX7 LUZP1 MTSS2 | 5.87e-04 | 747 | 26 | 11 | HP:0025783 |
| HumanPheno | Wide nasal bridge | 6.01e-04 | 508 | 26 | 9 | HP:0000431 | |
| HumanPheno | Abnormal 5th finger morphology | 6.09e-04 | 509 | 26 | 9 | HP:0004207 | |
| HumanPheno | Hirsutism | 6.12e-04 | 216 | 26 | 6 | HP:0001007 | |
| HumanPheno | Abnormal thought pattern | 6.37e-04 | 404 | 26 | 8 | HP:5200269 | |
| HumanPheno | Gastroesophageal reflux | 6.84e-04 | 517 | 26 | 9 | HP:0002020 | |
| HumanPheno | Dental crowding | 6.86e-04 | 144 | 26 | 5 | HP:0000678 | |
| Domain | SEA | 5.65e-10 | 23 | 82 | 6 | PS50024 | |
| Domain | SEA_dom | 5.65e-10 | 23 | 82 | 6 | IPR000082 | |
| Domain | SEA | 2.80e-09 | 14 | 82 | 5 | SM00200 | |
| Domain | SEA | 3.58e-08 | 22 | 82 | 5 | PF01390 | |
| Domain | - | 3.57e-05 | 15 | 82 | 3 | 3.30.70.960 | |
| Domain | SAPAP | 1.89e-04 | 5 | 82 | 2 | IPR005026 | |
| Domain | GKAP | 1.89e-04 | 5 | 82 | 2 | PF03359 | |
| Domain | WxxW_domain | 2.82e-04 | 6 | 82 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.82e-04 | 6 | 82 | 2 | PF13330 | |
| Domain | LAM_G_DOMAIN | 6.16e-04 | 38 | 82 | 3 | PS50025 | |
| Domain | EGF_1 | 8.99e-04 | 255 | 82 | 6 | PS00022 | |
| Domain | EGF-like_CS | 1.01e-03 | 261 | 82 | 6 | IPR013032 | |
| Domain | EGF_2 | 1.10e-03 | 265 | 82 | 6 | PS01186 | |
| Domain | WW | 1.15e-03 | 47 | 82 | 3 | PF00397 | |
| Domain | TIL | 1.22e-03 | 12 | 82 | 2 | PF01826 | |
| Domain | C8 | 1.22e-03 | 12 | 82 | 2 | PF08742 | |
| Domain | WW | 1.22e-03 | 48 | 82 | 3 | SM00456 | |
| Domain | Unchr_dom_Cys-rich | 1.44e-03 | 13 | 82 | 2 | IPR014853 | |
| Domain | C8 | 1.44e-03 | 13 | 82 | 2 | SM00832 | |
| Domain | WW_DOMAIN_2 | 1.46e-03 | 51 | 82 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 1.46e-03 | 51 | 82 | 3 | PS01159 | |
| Domain | WW_dom | 1.54e-03 | 52 | 82 | 3 | IPR001202 | |
| Domain | TIL_dom | 1.67e-03 | 14 | 82 | 2 | IPR002919 | |
| Domain | Ras_G-nucl-exch_fac_CS | 1.67e-03 | 14 | 82 | 2 | IPR019804 | |
| Domain | Laminin_G | 2.12e-03 | 58 | 82 | 3 | IPR001791 | |
| Domain | VWD | 2.20e-03 | 16 | 82 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.20e-03 | 16 | 82 | 2 | IPR001846 | |
| Domain | VWFD | 2.20e-03 | 16 | 82 | 2 | PS51233 | |
| Domain | VWD | 2.20e-03 | 16 | 82 | 2 | PF00094 | |
| Domain | UIM | 2.78e-03 | 18 | 82 | 2 | PF02809 | |
| Domain | CTCK_1 | 2.78e-03 | 18 | 82 | 2 | PS01185 | |
| Domain | VWC_out | 3.10e-03 | 19 | 82 | 2 | SM00215 | |
| Domain | BRCT | 3.10e-03 | 19 | 82 | 2 | PF00533 | |
| Domain | RasGEFN | 3.44e-03 | 20 | 82 | 2 | SM00229 | |
| Domain | EGF_3 | 3.76e-03 | 235 | 82 | 5 | PS50026 | |
| Domain | EGF | 3.76e-03 | 235 | 82 | 5 | SM00181 | |
| Domain | RasGEF_N | 3.79e-03 | 21 | 82 | 2 | PF00618 | |
| Domain | UIM | 3.79e-03 | 21 | 82 | 2 | SM00726 | |
| Domain | SRCR | 3.79e-03 | 21 | 82 | 2 | PF00530 | |
| Domain | Ras-like_Gua-exchang_fac_N | 4.15e-03 | 22 | 82 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 4.15e-03 | 22 | 82 | 2 | PS50212 | |
| Domain | CT | 4.15e-03 | 22 | 82 | 2 | SM00041 | |
| Domain | BRCT | 4.15e-03 | 22 | 82 | 2 | SM00292 | |
| Domain | - | 4.54e-03 | 23 | 82 | 2 | 3.40.50.10190 | |
| Domain | EGF-like_dom | 4.80e-03 | 249 | 82 | 5 | IPR000742 | |
| Domain | UIM | 4.94e-03 | 24 | 82 | 2 | PS50330 | |
| Domain | SR | 5.35e-03 | 25 | 82 | 2 | SM00202 | |
| Domain | - | 5.35e-03 | 25 | 82 | 2 | 3.10.250.10 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.95e-11 | 16 | 61 | 6 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 6.08e-11 | 17 | 61 | 6 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 4.86e-10 | 23 | 61 | 6 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.10e-09 | 26 | 61 | 6 | M27483 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.57e-08 | 68 | 61 | 7 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.48e-08 | 21 | 61 | 5 | MM15706 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.72e-07 | 143 | 61 | 8 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.60e-07 | 62 | 61 | 6 | M546 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.77e-07 | 111 | 61 | 7 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.84e-06 | 60 | 61 | 5 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.31e-06 | 109 | 61 | 6 | MM15164 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.14e-05 | 250 | 61 | 8 | M27554 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 3.05e-05 | 140 | 61 | 6 | M27484 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.98e-04 | 67 | 61 | 4 | MM15327 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 3.50e-04 | 32 | 61 | 3 | MM15326 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 3.83e-04 | 33 | 61 | 3 | M39875 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 5.40e-04 | 87 | 61 | 4 | M27617 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 1.09e-03 | 47 | 61 | 3 | M39518 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.26e-14 | 18 | 85 | 7 | 18834073 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EVL NCOR2 CARHSP1 MAP4 MDC1 DLGAP5 SAFB2 KMT2A AFDN RERE RFX7 POLA2 CCDC86 MEF2D TP53BP1 | 6.04e-10 | 774 | 85 | 15 | 15302935 |
| Pubmed | NCOR2 DLGAP1 NEDD4L NRXN1 TRIO DLGAP5 SAFB2 AFDN LMNB2 SPECC1L AGRN NEK9 TP53BP1 LUZP1 MTSS2 | 1.14e-08 | 963 | 85 | 15 | 28671696 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 26770020 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 10512748 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIAA1671 NHSL1 DLC1 NEDD4L TRIO MAP4 CCDC138 KMT2A AFDN RFX7 NEK9 MEF2D LUZP1 MTSS2 | 2.18e-08 | 861 | 85 | 14 | 36931259 |
| Pubmed | KIAA1671 EXOSC10 MAP4 MDC1 KMT2A AFDN SPECC1L SRCAP NEK9 TP53BP1 LUZP1 | 1.02e-07 | 549 | 85 | 11 | 38280479 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 19110483 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOR2 EXOSC10 MAP4 ATAD5 MDC1 DLGAP5 SAFB2 KMT2A AFDN CCDC86 MEF2D TP53BP1 LUZP1 | 5.47e-07 | 954 | 85 | 13 | 36373674 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KIAA1671 EVL ENDOD1 NCOR2 NRIP1 LRFN2 NEDD4L RHBDF2 ZNF608 TRIO MAP4 ANKIB1 RERE NEK9 NCK2 PDZD2 | 5.67e-07 | 1489 | 85 | 16 | 28611215 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NCOR2 EXOSC10 MAP4 MDC1 DLGAP5 SAFB2 ANKIB1 AFDN LMNB2 SRCAP CCDC86 AGRN NEK9 TP53BP1 LUZP1 | 9.12e-07 | 1353 | 85 | 15 | 29467282 |
| Pubmed | 3.58e-06 | 167 | 85 | 6 | 35833506 | ||
| Pubmed | 3.58e-06 | 167 | 85 | 6 | 22159717 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19098102 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17546051 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28194405 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12958310 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22750515 | ||
| Pubmed | The in vivo dynamic interplay of MDC1 and 53BP1 at DNA damage-induced nuclear foci. | 5.90e-06 | 2 | 85 | 2 | 22677490 | |
| Pubmed | Structural basis for synaptic adhesion mediated by neuroligin-neurexin interactions. | 5.90e-06 | 2 | 85 | 2 | 18084303 | |
| Pubmed | Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. | 5.90e-06 | 2 | 85 | 2 | 8205617 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18158901 | ||
| Pubmed | Agrin is involved in lymphocytes activation that is mediated by alpha-dystroglycan. | 5.90e-06 | 2 | 85 | 2 | 16394267 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20869594 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 5.90e-06 | 2 | 85 | 2 | 10973822 | |
| Pubmed | Neuroligin 1: a splice site-specific ligand for beta-neurexins. | 5.90e-06 | 2 | 85 | 2 | 7736595 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17884766 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9334251 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15797875 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16242404 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18986980 | ||
| Pubmed | SALM1 controls synapse development by promoting F-actin/PIP2-dependent Neurexin clustering. | 5.90e-06 | 2 | 85 | 2 | 31368584 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12796785 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16846852 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 5.90e-06 | 2 | 85 | 2 | 2393399 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11289722 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17360903 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16009723 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24695851 | ||
| Pubmed | Study of mucin turnover in the small intestine by in vivo labeling. | 5.90e-06 | 2 | 85 | 2 | 29636525 | |
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 5.90e-06 | 2 | 85 | 2 | 20873538 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29504935 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23264101 | ||
| Pubmed | Characterization of the interaction of a recombinant soluble neuroligin-1 with neurexin-1beta. | 5.90e-06 | 2 | 85 | 2 | 14522992 | |
| Pubmed | Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. | 5.90e-06 | 2 | 85 | 2 | 9417121 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25976740 | ||
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 5.90e-06 | 2 | 85 | 2 | 10405327 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KIAA1671 EXOSC10 NEDD4L MAP4 MDC1 SAFB2 UCK2 AFDN LMNB2 SPECC1L SRCAP CCDC86 | 7.26e-06 | 1024 | 85 | 12 | 24711643 |
| Pubmed | 9.35e-06 | 17 | 85 | 3 | 27779093 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.26e-05 | 208 | 85 | 6 | 33230847 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 28397142 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15684424 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 31801062 | ||
| Pubmed | Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis. | 1.77e-05 | 3 | 85 | 2 | 18504301 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 14695167 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 27230679 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 30236127 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20213761 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 1.77e-05 | 3 | 85 | 2 | 18163520 | |
| Pubmed | Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l. | 1.77e-05 | 3 | 85 | 2 | 23361907 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 22860035 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20065027 | ||
| Pubmed | RNF168 ubiquitylates 53BP1 and controls its response to DNA double-strand breaks. | 1.77e-05 | 3 | 85 | 2 | 24324146 | |
| Pubmed | Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals. | 1.77e-05 | 3 | 85 | 2 | 34320240 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 22307776 | ||
| Pubmed | Tyrosine kinase c-Abl couples RNA polymerase II transcription to DNA double-strand breaks. | 1.77e-05 | 3 | 85 | 2 | 30668775 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11352827 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16239140 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20113834 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20421415 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 17582332 | ||
| Pubmed | NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway. | 1.77e-05 | 3 | 85 | 2 | 19001859 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19718741 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.52e-05 | 351 | 85 | 7 | 38297188 | |
| Pubmed | 2.89e-05 | 645 | 85 | 9 | 25281560 | ||
| Pubmed | MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage. | 3.53e-05 | 4 | 85 | 2 | 17925396 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 25638393 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17471237 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 3.53e-05 | 4 | 85 | 2 | 22269464 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 14984930 | ||
| Pubmed | A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. | 3.53e-05 | 4 | 85 | 2 | 16901786 | |
| Pubmed | Astrocytes Assemble Thalamocortical Synapses by Bridging NRX1α and NL1 via Hevin. | 3.53e-05 | 4 | 85 | 2 | 26771491 | |
| Pubmed | Survival kinase genes present prognostic significance in glioblastoma. | 3.53e-05 | 4 | 85 | 2 | 26956052 | |
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 3.53e-05 | 4 | 85 | 2 | 29869461 | |
| Pubmed | Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1. | 3.53e-05 | 4 | 85 | 2 | 18664457 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21596555 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 25399301 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 23807779 | ||
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 3.53e-05 | 4 | 85 | 2 | 18198997 | |
| Pubmed | MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. | 3.53e-05 | 4 | 85 | 2 | 21293379 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12551934 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12676567 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12040032 | ||
| Pubmed | An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. | 3.53e-05 | 4 | 85 | 2 | 11565031 | |
| Pubmed | DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. | 3.53e-05 | 4 | 85 | 2 | 12556884 | |
| Pubmed | KIAA1671 NCOR2 ZNF608 ATAD5 MDC1 CCDC138 KMT2A RERE SRCAP RFX7 CCDC86 MEF2D TP53BP1 | 4.24e-05 | 1429 | 85 | 13 | 35140242 | |
| Pubmed | NHSL1 EVL DLGAP1 NEDD4L TRIO MAP4 MYO7A HECW2 KMT2A AFDN SPECC1L LUZP1 NCK2 | 4.30e-05 | 1431 | 85 | 13 | 37142655 | |
| Pubmed | EVL TCERG1L NRXN1 ABI3BP ZNF608 SBNO1 SAFB2 KMT2A ATP10B CEP295 LMNB2 SRCAP LUZP1 | 4.65e-05 | 1442 | 85 | 13 | 35575683 | |
| Pubmed | 5.20e-05 | 268 | 85 | 6 | 33640491 | ||
| Pubmed | 5.42e-05 | 396 | 85 | 7 | 26687479 | ||
| Interaction | NRXN1 interactions | 5.29e-08 | 127 | 83 | 8 | int:NRXN1 | |
| Interaction | WWTR1 interactions | KIAA1671 EXOSC10 KMT2A AFDN RTN4IP1 SPECC1L SRCAP NEK9 TP53BP1 LUZP1 | 9.07e-06 | 422 | 83 | 10 | int:WWTR1 |
| Interaction | YWHAH interactions | KIAA1671 NHSL1 NRIP1 DLGAP1 NEDD4L RHBDF2 TRIO CCDC138 KMT2A AFDN SPECC1L RFX7 POLA2 MEF2D LUZP1 MTSS2 | 9.26e-06 | 1102 | 83 | 16 | int:YWHAH |
| Interaction | ZZZ3 interactions | 2.36e-05 | 139 | 83 | 6 | int:ZZZ3 | |
| Interaction | TNIK interactions | 2.69e-05 | 381 | 83 | 9 | int:TNIK | |
| Interaction | KAT8 interactions | 4.55e-05 | 95 | 83 | 5 | int:KAT8 | |
| Interaction | YWHAQ interactions | KIAA1671 NHSL1 NRIP1 DLGAP1 NEDD4L NRXN1 MAP4 KMT2A ULK4 AFDN SPECC1L RFX7 MEF2D LUZP1 MTSS2 | 4.59e-05 | 1118 | 83 | 15 | int:YWHAQ |
| Interaction | FAM47A interactions | 5.01e-05 | 3 | 83 | 2 | int:FAM47A | |
| Interaction | MAP2 interactions | 7.01e-05 | 104 | 83 | 5 | int:MAP2 | |
| Cytoband | 7q22 | 4.93e-05 | 38 | 85 | 3 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 3.13e-04 | 316 | 85 | 5 | chr3p21 | |
| Cytoband | 19p13.3 | 1.01e-03 | 237 | 85 | 4 | 19p13.3 | |
| GeneFamily | CD molecules|Mucins | 5.27e-16 | 21 | 52 | 8 | 648 | |
| Coexpression | NABA_ECM_AFFILIATED | 7.61e-08 | 170 | 84 | 8 | M5880 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 5.66e-07 | 221 | 84 | 8 | M39222 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.20e-05 | 158 | 84 | 6 | MM17063 | |
| Coexpression | NABA_MATRISOME | FREM2 FNDC1 ABI3BP MUC17 COL27A1 MUC16 MUC5B MUC12 DMBT1 MUC2 MUC3A AGRN MUC20 | 2.23e-05 | 1026 | 84 | 13 | M5889 |
| Coexpression | E2F1_UP.V1_UP | 3.21e-05 | 188 | 84 | 6 | M2632 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 3.94e-05 | 195 | 84 | 6 | M45684 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 4.54e-05 | 200 | 84 | 6 | M8088 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 4.54e-05 | 200 | 84 | 6 | M7505 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.91e-08 | 179 | 84 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.10e-08 | 180 | 84 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.10e-08 | 180 | 84 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.44e-08 | 197 | 84 | 7 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.05e-07 | 200 | 84 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 7.92e-07 | 168 | 84 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.30e-06 | 183 | 84 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.35e-06 | 184 | 84 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.35e-06 | 184 | 84 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 190 | 84 | 6 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 190 | 84 | 6 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.62e-06 | 190 | 84 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.67e-06 | 191 | 84 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.72e-06 | 192 | 84 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.77e-06 | 193 | 84 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.77e-06 | 193 | 84 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-06 | 108 | 84 | 5 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-06 | 108 | 84 | 5 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.00e-06 | 197 | 84 | 6 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.00e-06 | 197 | 84 | 6 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.00e-06 | 197 | 84 | 6 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-06 | 199 | 84 | 6 | ef1a0c278c23614fd6a3218a9733abe6ecd6f686 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 84 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 84 | 6 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 84 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 84 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 173 | 84 | 5 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | 1.97e-05 | 174 | 84 | 5 | ebdddb5091afcc49ab533c890f260f709880c5f9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 84 | 5 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 84 | 5 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 84 | 5 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-05 | 180 | 84 | 5 | 8d9be9cfdf98e5888654a28ab12e5e89f201af00 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.32e-05 | 180 | 84 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 185 | 84 | 5 | 3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 185 | 84 | 5 | 995a8ddc3fd8e6879d8b5de8cbdefe232d34833b | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 186 | 84 | 5 | adba5647a2feaba8e361dc1020d2f2dc4ce36b16 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.71e-05 | 186 | 84 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.71e-05 | 186 | 84 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 186 | 84 | 5 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 2.78e-05 | 187 | 84 | 5 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 187 | 84 | 5 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 188 | 84 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 188 | 84 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 188 | 84 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.93e-05 | 189 | 84 | 5 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 189 | 84 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.00e-05 | 190 | 84 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 190 | 84 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-05 | 191 | 84 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 3.08e-05 | 191 | 84 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.08e-05 | 191 | 84 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.16e-05 | 192 | 84 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 193 | 84 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 3.23e-05 | 193 | 84 | 5 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 194 | 84 | 5 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 194 | 84 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.32e-05 | 194 | 84 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.32e-05 | 194 | 84 | 5 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 194 | 84 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.32e-05 | 194 | 84 | 5 | 5771a28a61f4d9b5479891f3224909ab003cb241 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 195 | 84 | 5 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 3.48e-05 | 196 | 84 | 5 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 197 | 84 | 5 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 197 | 84 | 5 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.65e-05 | 198 | 84 | 5 | 829377071f65016d31d09175a43c28e95532b404 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.65e-05 | 198 | 84 | 5 | 1eb49b853a9e144e840c660060473fc7873f6478 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.65e-05 | 198 | 84 | 5 | 27a3c1c5ac855dff8d63f44eaa289be3f5bd621a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.65e-05 | 198 | 84 | 5 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.65e-05 | 198 | 84 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 3.65e-05 | 198 | 84 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.83e-05 | 200 | 84 | 5 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 3.83e-05 | 200 | 84 | 5 | 372fe9018481a4e9ac6ab3af43705a48238c4376 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.24e-04 | 135 | 84 | 4 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-04 | 156 | 84 | 4 | 8790b4b400695571fcf1ccb24c658b5e90854ff7 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-04 | 157 | 84 | 4 | 0362c04b7b0b5017964b3a73ee678ae53e7238d7 | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 2.44e-04 | 161 | 84 | 4 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 164 | 84 | 4 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 164 | 84 | 4 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 164 | 84 | 4 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 166 | 84 | 4 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 166 | 84 | 4 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 8.31e-07 | 200 | 85 | 8 | 5454_UP | |
| Drug | rioprostil | 6.01e-06 | 32 | 85 | 4 | CID005311413 | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A | 8.52e-06 | 195 | 85 | 7 | 2727_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 8.81e-06 | 196 | 85 | 7 | 4419_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 9.11e-06 | 197 | 85 | 7 | 3939_DN | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 9.11e-06 | 197 | 85 | 7 | 4181_UP | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.00e-05 | 200 | 85 | 7 | 7015_DN | |
| Disease | Inhalant adrenergic use measurement | 7.79e-06 | 96 | 83 | 5 | EFO_0009941 | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.25e-05 | 64 | 83 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 1.40e-04 | 93 | 83 | 4 | C1535926 | |
| Disease | lithostathine-1-alpha measurement | 1.63e-04 | 7 | 83 | 2 | EFO_0801083 | |
| Disease | suberic acid measurement | 1.63e-04 | 7 | 83 | 2 | EFO_0010534 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 2.68e-04 | 110 | 83 | 4 | EFO_0803335 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 3.03e-04 | 766 | 83 | 9 | EFO_0004713, GO_0097366 | |
| Disease | glucagon-like peptide-1 measurement | 3.47e-04 | 10 | 83 | 2 | EFO_0008465 | |
| Disease | tauopathy (implicated_via_orthology) | 3.47e-04 | 10 | 83 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | plasminogen activator inhibitor 1 measurement | 4.80e-04 | 54 | 83 | 3 | EFO_0004792 | |
| Disease | cystic fibrosis (is_marker_for) | 7.20e-04 | 62 | 83 | 3 | DOID:1485 (is_marker_for) | |
| Disease | radiation-induced disorder | 9.03e-04 | 67 | 83 | 3 | EFO_0009565 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.07e-04 | 152 | 83 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | galectin-3 measurement | 9.14e-04 | 16 | 83 | 2 | EFO_0008137 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.03e-03 | 17 | 83 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | risk-taking behaviour | 1.39e-03 | 764 | 83 | 8 | EFO_0008579 | |
| Disease | eotaxin measurement | 1.51e-03 | 80 | 83 | 3 | EFO_0008122 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 1.59e-03 | 21 | 83 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | sensory peripheral neuropathy, remission | 1.90e-03 | 23 | 83 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | temperament and character inventory | 2.07e-03 | 24 | 83 | 2 | EFO_0004825 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 2.25e-03 | 25 | 83 | 2 | DOID:0050589 (implicated_via_orthology) | |
| Disease | migraine disorder, diastolic blood pressure | 2.25e-03 | 25 | 83 | 2 | EFO_0006336, MONDO_0005277 | |
| Disease | response to interferon | 2.25e-03 | 25 | 83 | 2 | EFO_0007859 | |
| Disease | pain | 2.30e-03 | 196 | 83 | 4 | EFO_0003843 | |
| Disease | S-warfarin measurement | 2.62e-03 | 97 | 83 | 3 | EFO_0803323 | |
| Disease | caudate volume change measurement, age at assessment | 2.62e-03 | 27 | 83 | 2 | EFO_0008007, EFO_0021491 | |
| Disease | optic disc size measurement | 2.71e-03 | 205 | 83 | 4 | EFO_0004832 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPTSKSTTRLDSDRV | 546 | P55196 | |
| PKSTRRSGRISSTPT | 591 | Q96QE3 | |
| ATTKRPVILTTSDPT | 1326 | Q96QE3 | |
| VRREKTTSTPDCTPT | 451 | F5H4B4 | |
| PESPESLTSVSRTRR | 16 | Q9H6F5 | |
| SSRPRTTASVPRTTV | 1021 | O00468 | |
| SPTASVTPTTRSRIR | 981 | Q69YQ0 | |
| RTPRTTRSSVTSPDE | 306 | Q9P2G1 | |
| LRSSSPPRTTTTVRT | 511 | O14490 | |
| PPRTTTTVRTIQSST | 516 | O14490 | |
| STTTEPRQRVTIKPS | 596 | O94823 | |
| ATATPSKTRTSTLLP | 2841 | Q9HC84 | |
| ATATPSKTRTSTLLP | 3541 | Q9HC84 | |
| RSVSVTSITSTVLPP | 626 | Q9NZL6 | |
| TEELTSTSSRTSPPR | 396 | Q9P2P5 | |
| RRTITSAAPTTSPIV | 2316 | Q8WXI7 | |
| SKEPSISPEIRSTVR | 3211 | Q8WXI7 | |
| TISRSIPKSSKTTRT | 4871 | Q8WXI7 | |
| RAVTSTTLPTLTLSP | 10996 | Q8WXI7 | |
| AVEPSTPTVLRSTST | 1886 | Q9Y618 | |
| TPTVLRSTSTSSPVR | 1891 | Q9Y618 | |
| TTLATSTARRGKPPT | 321 | P58400 | |
| TRSRTNRSSVKTPEP | 1146 | Q14676 | |
| STDRPVTPKPTSRTT | 1296 | Q14676 | |
| VTPKPTSRTTRSRTN | 1301 | Q14676 | |
| PVTPKPTSRTTRSRT | 1341 | Q14676 | |
| AKPSSTTPRLSRLAT | 911 | P27816 | |
| TSTRKQPPSSRLSSL | 1561 | Q9BY89 | |
| TKRPRSSTVTEAPIA | 326 | Q8TD19 | |
| RRKTSARDASPTPST | 81 | O43639 | |
| ISPARETRSFTKTSP | 86 | Q8N307 | |
| ATPTTARTRPTTDVS | 641 | Q8N307 | |
| RLKLSPSPSSRVTVS | 401 | Q03252 | |
| SSVPRRDSLSKTSTP | 4371 | Q2LD37 | |
| SSVTVRSRKTDPPSA | 2041 | Q5SZK8 | |
| STTTTTRRPTKKPRT | 441 | Q14118 | |
| LETASPPTRIRTTTS | 471 | Q14118 | |
| SSTRSKRSTLLPPEA | 306 | O94919 | |
| SRGSLRPPSTKEETS | 1051 | Q5SYE7 | |
| RTPSTKPTVRRALSS | 566 | Q765P7 | |
| RPSTLTTFTTITLPT | 1261 | Q02817 | |
| STTRTTERTPLPTGS | 221 | Q02505 | |
| SSPTRTILSSTPVLS | 286 | Q02505 | |
| TLVTTLPTTISRSTP | 316 | Q02505 | |
| STDIPTTSLRTLTPS | 2481 | Q02505 | |
| DTSIRTFVSPLTSPK | 1976 | O15018 | |
| SVEKPVSSILSRTPS | 331 | Q9UI08 | |
| RTSVIESPSTNRTTP | 536 | P48552 | |
| TTKVPSTDITFRPTR | 666 | Q8N2Q7 | |
| TTLATSTARRGKPPT | 1326 | Q9ULB1 | |
| TPSNSRTRKRPTSTS | 201 | A8MVS5 | |
| RTRKRPTSTSSSPET | 206 | A8MVS5 | |
| TREPRVLSATSATKS | 6 | Q01780 | |
| KVALPTNTTSSRPRT | 131 | Q96M89 | |
| LPSEKLERTSSVSPS | 331 | P51677 | |
| LPVPTSDRTTSRTSS | 201 | Q9BQY9 | |
| PRPTTATTRRTTTTR | 1466 | Q4ZHG4 | |
| VPRTVSSTTARKPVT | 216 | Q15398 | |
| TTSSSKKPIPTLART | 446 | Q8IZC6 | |
| PEPSSRRTQSSLTVS | 986 | Q86V48 | |
| TSSLRSEPPKTRRTS | 501 | Q5JRC9 | |
| SEPPKTRRTSSLRSE | 506 | Q5JRC9 | |
| EVRVRSPTRSPSVKT | 156 | Q03164 | |
| LSIEKPRTASTETPR | 2456 | Q9C0D2 | |
| SRSTPRPDTLSTITL | 706 | Q9UGM3 | |
| TTASTRPSVSAPTVR | 126 | A3KN83 | |
| TPTVPRISRTAITTA | 306 | Q8IXS8 | |
| ISIKSEPVSPSRERS | 436 | Q14814 | |
| TEGRTPLTSITVRTT | 1686 | Q685J3 | |
| PLTSITVRTTPVASS | 1691 | Q685J3 | |
| VTTIRISITSERSTP | 3861 | Q685J3 | |
| SSTTRTTERTPLPTG | 221 | Q9H195 | |
| SSRQDTTPTRPTLLI | 51 | P21217 | |
| QKPSVRRISTTSPRS | 26 | Q8WWV3 | |
| SRRKSLPSPSLSSSV | 6 | Q9H6Q3 | |
| TSSPVRARKLSLTSP | 736 | O14827 | |
| TPVVSSTPRLTTSER | 51 | Q9NZE8 | |
| RPRPVVTTTTSTTVV | 141 | Q8N114 | |
| TKSVTRPTRSSAEIT | 26 | A0A0B4J1U4 | |
| RIKTRTASTPVNTPS | 461 | Q9P2R6 | |
| STPETPLTKRSVSTR | 126 | Q14181 | |
| NTVTTVTISTSPPKR | 2991 | Q6ZRS2 | |
| TTATLTPQAPRERTT | 696 | A1L4H1 | |
| SAVSTPSPVTRTRSL | 751 | Q96QB1 | |
| TSRARSVSISVPSTP | 241 | Q96K30 | |
| STPPSVTSKSRVSRL | 221 | Q13433 | |
| SPLPTRRTRTFSATV | 41 | Q9Y2V2 | |
| KIPLRTSPVSDTRTE | 276 | Q5VWI1 | |
| ISRSPTLTRSVDVPS | 76 | Q8N412 | |
| SSARPRPSTDVKSQT | 351 | Q9HAH1 | |
| TIRSPTTVLFTSSPI | 346 | Q2KHR2 | |
| PVISVKTTSRSKERS | 581 | Q14151 | |
| STTPTRKITESPRAS | 1646 | Q12888 | |
| KSFRTPTIRSITPLS | 141 | Q86WI1 | |
| TPSRKRQASESSSRP | 246 | Q9BZX2 | |
| SLTRSPPTASQTRTL | 6 | A8MUU9 | |
| ASLTRTPPTASLTRT | 271 | A8MUU9 | |
| RTIPSLTSTSTPLRS | 181 | Q86T82 | |
| FTTVIPSKVSSPARR | 16 | Q8TAG6 | |
| KRVRTNSRSTPTTPQ | 521 | Q9ULD9 | |
| RKRRSTPLTSSTLPS | 11 | Q9UDV6 | |
| RPTTVTPETVPRSTK | 326 | Q7Z7G0 | |
| VSSVSSSRLQSRKPP | 11 | Q6PJF5 | |
| TASARTKPRPSAVTT | 236 | Q9NSU2 | |
| SSRLLVRPTSSETPS | 1891 | O75962 | |
| LSSRPTPRTSTAVEV | 361 | Q96C45 | |
| FPRSTTTSVRREEPT | 3956 | Q9UKN1 | |
| TSRTAPPKSRLSDIT | 386 | Q9ULH4 | |
| TSRTLITRGETVSTP | 371 | Q13402 | |
| IRRPRSLSSPTVTLS | 441 | Q96PU5 |